The overall aim of the call is to fund projects showing clinical feasibility of PM in complex diseases (including multifactorial, monogenic and other diseases). By feasibility is meant the demonstration of significant and clinically relevant improvement of current diagnostics and/or therapeutics, based on improved understanding of underlying molecular mechanisms. Applicants are expected to combine pre-clinical and/or clinical research with bio-informatics components to enable data quality on one side and the potential applicability for health care providers on the other side.
Funding Details: The total amount available to Canadian researchers from CIHR and FRQS is $4,587,500 CAD, enough to fund ten (10) grants. This amount may increase if additional funding partners participate. The maximum amount available is $150,000 CAD per year for up to three (3) years for a total of $450,000 CAD, per grant.
Internal HRS Deadline: June 21, 2018
Sponsor Deadline: July 5, 2018